Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →GFL reported a weak Q2 FY24 with consolidated revenue of INR 947 crore (down 35% YoY), EBITDA of INR 163 crore (down 70% YoY), and PAT of INR 53 crore (down 85% YoY).
✓ Verified against BSE filing
GFL reported a weak Q2 FY24 with consolidated revenue of INR 947 crore (down 35% YoY), EBITDA of INR 163 crore (down 70% YoY), and PAT of INR 53 crore (down 85% YoY). The sharp decline was driven by simultaneous headwinds across all segments: refrigerant export volume drops due to US phase-out, low-end PTFE price erosion from Chinese dumping, and destocking in higher-grade fluoropolymers. Management expects H2 to improve as destocking wanes and legacy player exits create opportunities, but FY24 margins will remain below the 30% target. FY25 is guided to be better than FY23. Key risk: continued pricing pressure from Chinese competition in commodity fluoropolymers.
GFL ने दूसरी तिमाही में कमजोर प्रदर्शन दिखाया। कंपनी की कुल कमाई 947 करोड़ रुपये रही, जो पिछले साल से 35% कम है। कमाई में भारी गिरावट की वजहें हैं: अमेरिका में रेफ्रिजरेंट के निर्यात में कमी, चीन से सस्ते PTFE प्लास्टिक की बाढ़, और महंगे फ्लोरोपॉलीमर की मांग में कमी। कंपनी को उम्मीद है कि साल की दूसरी छमाही में सुधार होगा, लेकिन इस साल मुनाफा 30% के लक्ष्य से कम रहेगा। अगले साल इससे बेहतर प्रदर्शन की उम्मीद है। मुख्य चिंता: चीनी कंपनियों से सस्ते उत्पादों की प्रतिस्पर्धा।
0 delivered, 0 close, 1 missed.
View Promises →Chinese dumping in low-end PTFE
View Risks →Full transcript text is available on this route.
Read Transcript →Low-end PTFE prices dropped sharply due to Chinese and Russian dumping, impacting margins.
GFL holds ~10% global market share in CTFE, a key fluoropolymer segment.
PVDF demand expected to quadruple by 2030, driven by EV and solar applications.
Management expects asset turnover of 2x for battery chemical investments, with full utilization by FY26.
Management expects FY25 to be better than FY23, implying recovery to peak levels.
Management reaffirms 30% EBITDA margin as normal run-rate, expecting to achieve it in FY25.
Management expects gradual improvement in H2 due to destocking phasing out and legacy player exits.
Integrated LiPF6 and electrolyte plants are in advanced commissioning; customer sampling imminent.
Management expects business environment to pick up from Q3 onwards and normalize by end of FY24.
Planned CapEx for FY24 may not be fully incurred this year; some may spill into next fiscal.
LiPF6 and electrolyte plants expected to come online by end of Q2 FY24, with meaningful revenue in FY25.
Management expects EBITDA margins to remain in the 28-33% range for the full year.
Continued price pressure from Chinese and Russian competitors in commodity PTFE grades may persist, impacting margins.
US phase-out of R125 and circumvention issues have structurally impacted export volumes; recovery may be limited.
High-cost inventory led to gross margin compression; normalization may take another quarter.
Despite management's confidence, PFAS regulations in Europe and US could impact fluoropolymer demand if scope widens.
Destocking may persist longer than expected, delaying volume ramp-up and capacity utilization.
Weak summer in domestic and overseas markets impacted refrigerant sales; Q2 expected to be similar to Q1.
Excess Chinese capacity and slowdown in EV sector are pressuring PVDF prices and volumes.
Approval processes for battery-grade PVDF and semiconductor-grade PFA are taking longer than expected.
Management expects FY25 to be better than FY23, implying recovery to peak levels.
Continued price pressure from Chinese and Russian competitors in commodity PTFE grades may persist, impacting margins.
View Risks →